This is a randomized RTC study where the KOS-ADLS score of athletes' functionality and the OSTRC score of sports overuse injuries were used as outcomes, which were measured before the start of treatment, 1 hour and 2 weeks after treatment. In this study, 3 forms of intervention were used: Mulligan, Kinesiotaping and placebo in young basketball players with knee injuries.
Study type: Randomized Clinical Trial RTC ,with three intervention groups. Population: young basketball players. The intervention will last 2 weeks. Outcomes: KOS-ADLS; OSTRC. Statistical analysis: Mixed ANOVA
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
Participants received the MWM technique in a squat position with a tibial glide by a physiotherapist certified in the mulligan concept twice a week for 2 weeks, the treatment lasted 5 minutes.
Participants received the same kinesiotaping pattern regardless of injury type twice a week for 2 weeks for 5 minutes.
Participants received a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks, lasting 5 minutes.
Sports Club Training facilities
Tirana, Tirana, Albania
KOS-SAS (ADLS)
The Activities of Daily Living Scale (ADLS) subscale of the Knee Outcome Survey evaluates symptoms and functional limitations during daily activities. Scores range from 0 to 100, with higher scores indicating better function.
Time frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
Overuse Injury Questionnaire - Oslo Sports Trauma Research Center (OSTRC)
The Oslo Sports Trauma Research Center (OSTRC) Overuse Injury Questionnaire is a validated self-report instrument used to monitor the severity and impact of overuse-related musculoskeletal problems. It evaluates the consequences of knee-related problems on sports participation, training volume, sports performance, and symptom severity. Responses to the four key questions are converted into a severity score ranging from 0 to 100, where higher scores indicate greater symptom severity and functional impairment.
Time frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.